Advanced Glycation End Products (AGE)-Modified Proteins and Their Potential Relevance to Atherosclerosis

This publication has 40 references indexed in Scilit:

• N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue Proteins
  Biochemistry, 1995
• Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• STRUCTURES AND FUNCTIONS OF MULTILIGAND LIPOPROTEIN RECEPTORS: Macrophage Scavenger Receptors and LDL Receptor-Related Protein (LRP)
  Annual Review of Biochemistry, 1994
• beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.
  Journal of Clinical Investigation, 1993
• Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins.
  Journal of Clinical Investigation, 1992
• Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.
  The Journal of Experimental Medicine, 1991
• Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins.
  The Journal of Experimental Medicine, 1991
• Scavenger receptor-mediated recognition of maleylated albumin and its relation to subsequent endocytic degradation
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1989
• LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
  Annual Review of Biochemistry, 1983
• THE USE OF FORMALDEHYDE-TREATED 131I-ALBUMIN IN THE STUDY OF DIGESTIVE VACUOLES AND SOME PROPERTIES OF THESE PARTICLES FROM MOUSE LIVER
  The Journal of cell biology, 1967